BB Biotech AG (BION) — Cash Flow Quality Index

Latest as of June 2026: -0.33x

BB Biotech AG (BION) has a Cash Flow Quality Index of -0.33x as of June 2026. Operating cash flow of CHF-150.88 Million is below net income of CHF451.17 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore BION operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.33x
Operating CF / Net Income

Operating Cash Flow

CHF-150.88 Million
CHF

Net Income

CHF451.17 Million
CHF

Data as of

Jun 2026
Most recent filing

BB Biotech AG Cash Flow Quality Index (2003–2025)

Historical Cash Flow Quality Index for BB Biotech AG across 15 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see BION cash flow conversion.

Annual Cash Flow Quality Index for BB Biotech AG (2003–2025)

Year-by-year earnings quality comparison for BB Biotech AG.

Year Quality Index Operating CF (CHF) Net Income YoY Change
2025 0.53x CHF309.14 Million CHF578.13 Million ▼ -86.7%
2024 4.01x CHF304.56 Million CHF75.90 Million ▲ +956.8%
2020 0.38x CHF262.45 Million CHF691.17 Million ▲ +19.6%
2019 0.32x CHF215.02 Million CHF677.43 Million ▼ -68.3%
2017 1.00x CHF687.50 Million CHF687.50 Million ▲ +0.0%
2015 1.00x CHF652.82 Million CHF652.82 Million ▲ +0.0%
2014 1.00x CHF1.47 Billion CHF1.47 Billion ▲ +0.0%
2013 1.00x CHF931.83 Million CHF931.83 Million ▲ +0.0%
2012 1.00x CHF367.83 Million CHF367.83 Million ▼ -78.2%
2009 4.58x CHF167.84 Million CHF36.63 Million ▼ -59.2%
2008 11.23x CHF509.39 Million CHF45.35 Million ▲ +16966.5%
2006 -0.07x CHF-19.80 Million CHF297.39 Million ▼ -244.8%
2005 -0.02x CHF-6.14 Million CHF317.99 Million ▼ -103.6%
2004 0.53x CHF107.32 Million CHF202.75 Million ▲ +155.1%
2003 -0.96x CHF-172.22 Million CHF179.34 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.